On the reverse of that, they have a company that could go idle for a while trying to figure what to do with trials and effectively management have lined themselves up with continuous wage for several years.
Just say IIH scraped then they would have to start again with TBI, prep trials etc could be years and they have tons of cash. I wouldn't mind being a Director in a company like. Decent wage with no end sight for a while.
This is effectively a shell now if IIH trials are scraped. A negative 5 mill EV shell. What I want to know is what happens to the trial sites and all those consultants they hired if trials are obsolete?
My biggest warning sign was management not buying on market even near cashbacking.
Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-77
-
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable